Stockreport

Verona Pharma down 30% on uncertainty with Phase 3 ensifentrine study [Seeking Alpha]

Verona Pharma plc - American Depositary Shares  (VRNA) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/vrna/real-time
PDF Thinly traded nano cap Verona Pharma (VRNA-30.1%disclosureIn January, it announcedpositive results [Read more]